Israel in talks for Pfizer's vaccine, official says
US drug company Pfizer said on Monday that its COVID-19 vaccine is more than 90% effective.
![GettyImages-1229555002.jpg](/sites/default/files/styles/article_hero_medium/public/almpics/2020/11/GettyImages-1229555002.jpg/GettyImages-1229555002.jpg?h=a5ae579a&itok=HhP2nbHK)
The Israeli government is in talks to acquire the Pfizer-produced coronavirus vaccine, which the American drugmaker said Monday is more than 90% effective in preventing COVID-19.
Pfizer, which developed its experimental vaccine with German partner BioNTech, announced on Monday promising findings following phase 3 of the clinical trial. An initial analysis indicated an efficacy rate of more than 90% among participants without evidence of a prior COVID-19 infection.